On the Move: Who's Going Where in Biopharma and Medtech Start-ups
This article was originally published in Start Up
Executive SummaryRecent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.
You may also be interested in...
A Roche director joins predictive drug discovery firm Compugen and a Bristol-Myers Squibb exec is welcomed at immuno-oncology company Turnstone Biologics – both in Business Development. And China- and US-based biopharma Antegene brings on Celgene manager as CBO.
The CEO of Ipsen Group departs to take top job at new gene therapy company FerGene and Novo Nordisk’s VP, regulatory affairs moves to EVP, quality and regulatory at Scandinavian orthobiologics firm BoneSupport. At commercial-stage pharma business PDL BioPharma, a chairperson is elected.
New CEOs for Abgenomics, Advangen, Dynavax Technologies, Merus and Nuvelution are among the latest biopharma appointments. Kiadis Pharma’s CFO’s resignation takes effect on 31 December.